Everyone's talking about the upcoming SpaceX and Anthropic IPOs like they're the opportunity of the decade. And maybe they are—if you can actually get shares. But here's the thing Wall Street doesn't want you to focus on: you probably can't.

Welcome to the two-tier market, where institutional investors and venture capital firms get first crack at the next big thing, and retail investors like you and me get to fight over the scraps at inflated prices.

Let's be clear about what's happening. SpaceX is valued at over $200 billion in private markets. By the time it goes public, the early investors—the venture funds, the insiders, the "qualified" buyers—will have already made their money. The IPO isn't about giving you opportunity. It's about giving them an exit.

But let's say you still want exposure to SpaceX before or after the IPO. What are your actual options?

Option 1: Buy Alphabet. Google's parent company owns about 6.1% of SpaceX. Sounds good, until you realize Alphabet is a $2 trillion company. Even if SpaceX doubles in value overnight, it'll move Alphabet's stock price by maybe 5%. You're buying a massive conglomerate to get a tiny slice of SpaceX exposure.

Option 2: ARK Venture Fund (ARKVX). Cathie Wood's fund holds SpaceX and other private companies. But here's the rub: it's illiquid, it has high fees, and Cathie's track record post-COVID hasn't exactly been stellar. You're betting on her stock-picking ability, not just SpaceX.

Option 3: EchoStar (SATS). This is the most direct play—they're set to acquire about $11 billion worth of SpaceX stock through a spectrum deal. The problem? EchoStar is otherwise a dying business. You're essentially making a leveraged bet on SpaceX while holding a melting ice cube. High risk, potentially high reward, but not exactly a safe play.

Option 4: Wait for the IPO and buy on day one. Good luck. Retail investors typically get allocated tiny amounts of shares in hot IPOs, if any at all. By the time you can buy freely on the open market, the price has usually already popped. You're buying the top.

Here's what frustrates me about this whole situation: the people with the most access to financial opportunity—the venture capitalists, the institutional investors, the ultra-wealthy—are also the ones who need it least. Meanwhile, regular investors who could actually benefit from early-stage exposure get locked out by rules designed to us.